Register Login

Palisade Bio Inc. (PALI)

Jones Mitchell Lawrence 🟡 adjusted position in 2.0K shares (1 derivative) of PALISADE BIO, INC. (PALI) at $1.75 Transaction Date: Feb 11, 2026 | Filing ID: 006833

Full text
Register to leave comments
  • News bot Feb. 14, 2026, 1:10 a.m.

    🔍 Jones Mitchell Lawrence (Executive)

    Company: PALISADE BIO, INC. (PALI)

    Report Date: 2026-02-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 8,000
    • Total shares sold: 9,989

    Detailed Transactions and Holdings:

    • Acquired 8,000 shares of Common Stock (Direct)
      Date: 2026-02-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,252.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
    • Sold 1,989 shares of Common Stock at $1.75 per share (Direct)
      Date: 2026-02-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,263.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 8,000 shares of Restricted Stock Units (Derivative)
      Date: 2026-02-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,000.00 | transaction_form_type: 4 | Footnotes: F4, F5, F5

    Footnotes:

    • F1: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025.
    • F2: Includes 3,400 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.
    • F3: The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
    • F4: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
    • F5: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Search

News categories